Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Shabir Ahmad Ganai, Shashwath Malli Kalladi & Vijayalakshmi Mahadevan. (2015) HDAC inhibition through valproic acid modulates the methylation profiles in human embryonic kidney cells. Journal of Biomolecular Structure and Dynamics 33:6, pages 1185-1197.
Read now
Read now
Articles from other publishers (28)
Steven Behnisch-Cornwell, Christoph W. Grathwol, Lukas Schulig, Anika Voigt, Daniel Baecker, Andreas Link & Patrick J. Bednarski. (2021) Correlation Analysis of Protein Expression of 10 HDAC/Sirtuin Isoenzymes with Sensitivities of 23 Anticancer Drugs in 17 Cancer Cell Lines and Potentiation of Drug Activity by Co-Treatment with HDAC Inhibitors. Cancers 14:1, pages 187.
Crossref
Crossref
Ekta Shirbhate, Preeti Patel, Vijay K Patel, Ravichandran Veerasamy, Prabodh C Sharma & Harish Rajak. (2020) The combination of histone deacetylase inhibitors and radiotherapy: a promising novel approach for cancer treatment. Future Oncology 16:30, pages 2457-2469.
Crossref
Crossref
Yu Bai, Daid Ahmad, Ting Wang, Guihua Cui & Wenliang Li. (2019) Research Advances in the Use of Histone Deacetylase Inhibitors for Epigenetic Targeting of Cancer. Current Topics in Medicinal Chemistry 19:12, pages 995-1004.
Crossref
Crossref
J.M. Goodrich & D.C. Dolinoy. 2018. Comprehensive Toxicology. Comprehensive Toxicology
271
288
.
Aleksandra Pettke, Marc Hotfilder, Dagmar Clemens, Stephanie Klco-Brosius, Christiane Schaefer, Jenny Potratz & Uta Dirksen. (2016) Suberanilohydroxamic acid (vorinostat) synergistically enhances the cytotoxicity of doxorubicin and cisplatin in osteosarcoma cell lines. Anti-Cancer Drugs 27:10, pages 1001-1010.
Crossref
Crossref
M M Olcina, S O'Dell & E M Hammond. (2015) Targeting chromatin to improve radiation response. The British Journal of Radiology 88:1047, pages 20140649.
Crossref
Crossref
C. Tzao, J.-S. Jin, B.-H. Chen, H.-Y. Chung, C.-C. Chang, T.-Y. Hsu & G.-H. Sun. (2014)
Anticancer effects of suberoylanilide hydroxamic acid in esophageal squamous cancer cells
in vitro
and
in vivo
. Diseases of the Esophagus 27:7, pages 693-702.
Crossref
Crossref
Jane J. Sung, Katherine Ververis & Tom C. Karagiannis. (2014) Histone deacetylase inhibitors potentiate photochemotherapy in cutaneous T-cell lymphoma MyLa cells. Journal of Photochemistry and Photobiology B: Biology 131, pages 104-112.
Crossref
Crossref
Yuko Ibuki. (2014) Histone Modifications Induced by Chemicals and Photogenotoxicity. Genes and Environment 36:3, pages 111-117.
Crossref
Crossref
Mario Solís-Paredes, Pilar Eguía-Aguilar, Fernando Chico-Ponce de León, Stanislaw Sadowinski-Pine, Mario Pérezpeña-Diazconti & Francisco Arenas-Huertero. (2013) Epigenetic modifications in cell lines of human astrocytoma differentially regulate expression of apoptotic genes. Child's Nervous System 30:1, pages 123-129.
Crossref
Crossref
Jane Jisun Sung & Tom C. Karagiannis. 2014. Molecular mechanisms and physiology of disease. Molecular mechanisms and physiology of disease
445
470
.
H Stedt, H Samaranayake, J Pikkarainen, A M Määttä, L Alasaarela, K Airenne & S Ylä-Herttuala. (2013) Improved therapeutic effect on malignant glioma with adenoviral suicide gene therapy combined with temozolomide. Gene Therapy 20:12, pages 1165-1171.
Crossref
Crossref
Kiren Yacqub-Usman, Alan Richardson, Cuong V. Duong, Richard N. Clayton & William E. Farrell. (2012) The pituitary tumour epigenome: aberrations and prospects for targeted therapy. Nature Reviews Endocrinology 8:8, pages 486-494.
Crossref
Crossref
Sung-Keum Seo, Hyeon-Ok Jin, Sang-Hyeok Woo, Young-Sun Kim, Sungkwan An, Jae-Ho Lee, Seok-Il Hong, Kee-Ho Lee, Tae-Boo Choe & In-Chul Park. (2011) Histone Deacetylase Inhibitors Sensitize Human Non-small Cell Lung Cancer Cells to Ionizing Radiation Through Acetyl p53-Mediated c-myc Down-Regulation. Journal of Thoracic Oncology 6:8, pages 1313-1319.
Crossref
Crossref
Amy R. Johnson. 2011. Nutrition in Epigenetics. Nutrition in Epigenetics
127
143
.
Benjamin Briggs, Katherine Ververis, Annabelle L. Rodd, Laura J.L. Foong, Fernando M. Da Silva & Tom C. Karagiannis. (2011) Photosensitization by iodinated DNA minor groove binding ligands: Evaluation of DNA double-strand break induction and repair. Journal of Photochemistry and Photobiology B: Biology 103:2, pages 145-152.
Crossref
Crossref
Heather R Pelzel, Cassandra L Schlamp & Robert W Nickells. (2010) Histone H4 deacetylation plays a critical role in early gene silencing during neuronal apoptosis. BMC Neuroscience 11:1.
Crossref
Crossref
Giovanni Di Bernardo, Nicola Alessio, Carmela Dell'Aversana, Fiorina Casale, Diana Teti, Marilena Cipollaro, Lucia Altucci & Umberto Galderisi. (2010) Impact of histone deacetylase inhibitors SAHA and MS‐275 on DNA repair pathways in human mesenchymal stem cells. Journal of Cellular Physiology 225:2, pages 537-544.
Crossref
Crossref
Luke A. Wittenburg, Daniel L. Gustafson & Douglas H. Thamm. (2010) Phase I Pharmacokinetic and Pharmacodynamic Evaluation of Combined Valproic Acid/Doxorubicin Treatment in Dogs with Spontaneous Cancer. Clinical Cancer Research 16:19, pages 4832-4842.
Crossref
Crossref
Tom C Karagiannis, Ann JE Lin, Katherine Ververis, Lisa Chang, Michelle M Tang, Jun Okabe & Assam El-Osta. (2010) Trichostatin A accentuates doxorubicin-induced hypertrophy in cardiac myocytes. Aging 2:10, pages 659-668.
Crossref
Crossref
Marco Wachtel & Beat W. Schäfer. (2010) Targets for cancer therapy in childhood sarcomas. Cancer Treatment Reviews 36:4, pages 318-327.
Crossref
Crossref
Allison JonesMatthias LechnerEvangelia-Ourania FourkalaRebecca Kristeleit & Martin Widschwendter. (2010) Emerging promise of epigenetics and DNA methylation for the diagnosis and management of women’s cancers. Epigenomics 2:1, pages 9-38.
Crossref
Crossref
Jarah A. Meador, Yanrong Su, Jean-Luc Ravanat & Adayabalam S. Balajee. (2010) DNA-dependent protein kinase (DNA-PK)-deficient human glioblastoma cells are preferentially sensitized by Zebularine. Carcinogenesis 31:2, pages 184-191.
Crossref
Crossref
D.C. Dolinoy. 2010. Comprehensive Toxicology. Comprehensive Toxicology
293
309
.
Connie C. Cortez & Peter A. Jones. (2008) Chromatin, cancer and drug therapies. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 647:1-2, pages 44-51.
Crossref
Crossref
Olaia Martínez-Iglesias, Lidia Ruiz-Llorente, Ruth Sánchez-Martínez, Laura García, Alberto Zambrano & Ana Aranda. (2008) Histone deacetylase inhibitors: mechanism of action and therapeutic use in cancer. Clinical and Translational Oncology 10:7, pages 395-398.
Crossref
Crossref
Christian A. Hassig, Kent T. Symons, Xin Guo, Phan-Manh Nguyen, Tami Annable, Paul L. Wash, Joseph E. Payne, David A. Jenkins, Céline Bonnefous, Carol Trotter, Yan Wang, John V. Anzola, Elena L. Milkova, Timothy Z. Hoffman, Sara J. Dozier, Brandon M. Wiley, Alan Saven, James W. Malecha, Robert L. Davis, Jerry Muhammad, Andrew K. Shiau, Stewart A. Noble, Tadimeti S. Rao, Nicholas D. Smith & Jeffrey H. Hager. (2008)
KD5170, a novel mercaptoketone-based histone deacetylase inhibitor that exhibits broad spectrum antitumor activity
in vitro
and
in vivo
. Molecular Cancer Therapeutics 7:5, pages 1054-1065.
Crossref
Crossref
Jennifer R. Weidman, Dana C. Dolinoy, Susan K. Murphy & Randy L. Jirtle. (2007) Cancer Susceptibility: Epigenetic Manifestation of Environmental Exposures. The Cancer Journal 13:1, pages 9-16.
Crossref
Crossref